I wasn't aware that CBO had done a comprehensive analysis of how that bill will increase premiums.

I fought for years to enact common sense reforms that will slow down health care cost growth.

The status quo in health care is unacceptable. Health care costs are skyrocketing, insurance premiums are increasing.

I happen to be one who believes strongly in the defined benefit pension program.

The challenge that you are going to have is that, once again, it is a paradigm shift that is going to happen through departments and agencies.

The drafters of ERISA back in the 1970s were careful not to have the PBGC give too generous of benefits in plans taken over by the PBGC.

I am dismayed to find now that after 3 years, that the bill we passed actually has propelled us more toward the defined contribution plan rather than defined benefit plan.

And our attempt is to make sure that the companies are not gaming the system at the same time.

I would challenge the Administration to look throughout the Government at where you could apply these ideas.

What kind of precedent is this setting for future pension plans that are taken over by the PBGC, and what does it say about the use of taxpayer dollars for the top-up?

Thank you, Mr. Chairman.

Taxpayers deserve to know how the Delphi situation is tied to the larger Federal bailout of GM.

We have been talking about this narrower corridor.

These are people that worked hard all their lives.

I believe we need to fundamentally reform the insurance market place and offer new protections to ensure that consumers--including people with pre-existing conditions--can buy affordable, high quality health insurance.

I strongly support ending all discrimination based on pre-existing conditions, whatever their cause.

Everyone should be able to get the health care coverage they need.

If this legislation is enacted, the risks of marketing a device will greatly increase.

This is not only a detriment to healthcare reform, but it undermines the primary healthcare reform goal of controlling the growth curve.

We have one of the most, if not the most, innovative and vibrant medical device industries in the world.

this misguided legislation would, among other things, stifle innovation, compromise the safety of American consumers, and threaten the preeminence of the U.S. medical device industry in the world community.

A high percentage of the lawsuits were brought to get defense costs. They were frivolous suits.

This legislation would supplant the findings of the FDA with those of juries in State courts.

which would limit access to innovative medical devices and technologies that can dramatically improve quality of life for aging and ailing veterans.

You know, you can't have a bipartisan bill that's written by one side and that's what it is.